Serum retinol-binding protein, obesity, and insulin resistance

Vitamin-Binding Proteins: Functional Consequences

Volumn , Issue , 2013, Pages 31-48

  Bhat, Pangala V ^a   Manolescu, Daniel Constantin ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85054740857     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/b15313     Document Type: Chapter

References (141)

1. Abel, E. D., Peroni, O., Kim, J. K. et al. 2001. Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver. Nature 409: 729-733.
2. Aeberli, I., Biebinger, R., Lehmann, R. et al. 2007. Serum retinol-binding 4 concentrations and its ratio to serum retinol are associated with obesity and metabolic syndrome components in children. J Clin Endocrinol Metab 92: 4359-4365.
3. Akbay, E., Muslu, N., Nayir, E. et al. 2010. Serum retinol binding protein 4 levels is related with renal functions in type 2 diabetes. J Endocrinol Invest 33: 725-729.
4. Aleman, G., Torres, N., and Tovar A, R. 2004. Peroxisome proliferator-activated receptors (PPARs) in obesity, and insulin resistance development. Rev Invest Clin 56: 351-367.
5. An, C., Wang, H., Liu, X. et al. 2009. Serum retinol binding protein 4 is elevated and positively associated with insulin resistance in postmenopausal women. Endocr J 56: 987-996.
6. Balagopal, P., Graham, T. E., Kahn, B. B. et al. 2007. Reduction of elevated serum retinol binding protein in obese children by lifestyle intervention: Association with subclinical inflammation. J Clin Endocrinol Metab 92: 1971-1974.
7. Bernard, A., Vyskocyl, A., Mahieu, P. et al. 1988. Effect of renal insufficiency on concentration of free retinol-binding protein in urine and serum. Clin Chim Acta 171: 85-93.
8. Berry, D. C., Jin, H., Majumdar, A. et al. 2011. Signaling by vitamin A and retinol-binding protein regulates gene expression to inhibit insulin responses. Proc Natl Acad Sci USA 108: 4340-4345.
9. Bhat, P. V. 2005. Role of retinol dehydrogenase type 1 (RALDH1) in retinoic acid biosynthesis. Enzymol Mol Biol 12: 66-72.
10. Bhat, P. V. and Lacroix, A. 1983. Separation and estimation of retinyl fatty acyl esters in tissues of normal rat by high-performance liquid chromatography. J Chromatogr 272: 269-278.
11. Blaner, W. S. 1989. Retinol binding protein: The serum transport protein for vitamin A. Endocr Rev 10: 308-316.
12. Blaner, W. S. and Goodman, D. S. 1990. Purification and properties of plasma retinol-binding protein. Methods Enzymol 189: 193-206.
13. Bobbert, P., Weithauser, A., Andres, J. et al. 2009. Increased plasma retinol binding protein 4 levels in patients with inflammatory cardiomyopathy. Eur J Heart Fail 11: 1163-1168.
14. Broch, M., Gomez, J. M., Auguet, M. T. et al. 2010. Association of retinol-binding protein-4 (RBP4) with lipid parameters in obese women. Obes Surg 20: 1258-1264.
15. Broch, M., Vendrell, J., Ricart, W. et al. 2007. Circulating retinol-binding protein-4, insulin sensitivity, insulin secretion, and insulin disposition index in obese and nonobese subjects. Diabetes Care 30: 1802-1806.
16. Cabre, A., Lazaro, I., Girona, J. et al. 2007. Retinol-binding protein 4 as a plasma biomarker of renal dysfunction and cardiovascular disease in type 2 diabetes. J Intern Med 262: 496-503.
17. Chambon, P. 1996. A decade of molecular biology of retinoic acid receptors. FASEB J 10: 940-954.
18. Chan, T. F., Tsai, Y. C., Wu, C. H. et al. 2011. The positive correlation between cord serum retinol-binding protein 4 concentrations and fetal growth. Gynecol Obstet Invest 72: 98-102.
19. Chang, Y. H., Lin, K. D., Wang, C. L. et al. 2008. Elevated serum retinol-binding protein 4 concentrations are associated with renal dysfunction and uric acid in type 2 diabetic patients. Diabetes Metab Res Rev 24: 629-634.
20. Chavez, A. O,. Coletta, D. K., Kamath, S. et al. 2009. Retinol-binding protein 4 is associated with impaired glucose tolerance but not with whole body or hepatic insulin resistance in Mexican Americans. Am J Physiol Endocrinol Metab 296: E758-E764.
21. Chertow, B. S., Blaner, W. S., Baranetsky, N. G. et al. 1987. Effects of vitamin A deficiency and repletion on rat insulin secretion in vivo and in vitro from isolated islets. J Clin Invest 79: 163-169.
22. Chiefari, E., Paonessa, F., Liritano, S. et al. 2009. The cAMP-HMGA1-RBP4 system: A novel biochemical pathway for modulating glucose homeostasis. BMC Biol 21: 7-24.
23. Cho, Y. M., Youn, B. S., Lee, H. et al. 2006. Plasma retinol-binding protein-4 concentrations are elevated in human subjects with impaired glucose tolerance and type 2 diabetes. Diabetes Care 29: 2457-2461.
24. Choi, K. M., Yannakoulia, M., Park, M. S. et al. 2011. Serum adipocyte fatty acid-binding protein, retinol binding protein 4, and adiponectin concentrations in relation to the development of the metabolic syndrome in Korean boys: A 3-y prospective cohort study. Am J Clin Nutr 93: 19-26.
25. Conroy, R., Espinal, Y., Fennoy, I. et al. 2011. Retinol binding protein 4 is associated with adiposity-related co-morbidity risk factors in children. J Pediatr Endocrinol Metab 24: 913-919.
26. Craig, R. L., Chu, W. S., and Elbein, S. C. 2007. Retinol binding protein 4 as a candidate gene for type 2 diabetes and prediabetic intermediate traits. Mol Genet Metab 90: 338-344.
27. DeFronzo, R. A. 1997. Pathogenesis of type 2 diabetes: Metabolic and molecular implications for identifying diabetes gene. Diabetes Rev 5: 171-269.
28. Erikstrup, C., Mortensen, O. H., and Nielsen, A. R. 2008. RBP-to-retinol ratio, but not total RBP, is elevated in patients with type 2 diabetes. Diabetes Obes Metab 11: 204-212.
29. Fernandez-Real, J. M., Moreno, J. M., and Ricart, W. 2008. Circulating retinol-binding protein-4 concentration might reflect insulin resistance-associated iron overload. Diabetes 57: 1918-1925.
30. Friebe, D., Neef, M., Erbs, S. et al. 2011. Retinol binding protein 4 (RBP4) is primarily associated with adipose tissue mass in children. Int J Pediat Obes 6: e346-e352.
31. Frolik, C. A., Roberts, A. B., Tavela, T. E. et al. 1979. Isolation and identification of 4-hydroxy-and 4-oxoretinoic acid: In vitro metabolites of all-trans retinoic acid in hamster trachea and liver. Biochemistry 18:2092-2097.
32. Gavi, S., Stuart, L. M., Kelly, P. et al. 2007. Retinol-binding protein 4 is associated with insulin resistance and body fat distribution in nonobese subjects without type 2 diabetes. J Clin Endocrinol. Metab 92: 1886-1890.
33. Gerdes, S., Osadtschy, S., Rostami-Yazdi, M. et al. 2012. Leptin, adiponectin, visfatin and retinol-binding protein-4-mediators of comorbidities in patients with psoriasis. Exp Dermatol 21: 43-47.
34. Goodman, D. S. 1974. Vitamin A transport and RBP metabolism. Vitam Horm 32: 167-180.
35. Goodman, D. S. 1982. Retinoid-binding proteins. J Am Acad Dermatol 6: 583-590.
36. Goodman, E., Graham, T. E., Dolan, L. M. et al. 2009. The relationship of retinol binding protein 4 to changes in insulin resistance and cardiometabolic risk in overweight black adolescents. J Pediatr 154: 67-73.
37. Gottesman, M. E., Quadro, L., and Blaner, W. S. 2001. Studies of vitamin A metabolism in mouse model systems. BioEssays 23: 409-419.
38. Graham, T. E., Wason, C. J., Bluher, M. et al. 2007. Shortcomings in methodology complicate measurements of serum retinol binding protein (RBP4) in insulin-resistant human subjects. Diabetologia 50: 814-823.
39. Graham, T. E., Yang, Q., Bluher, M. et al. 2006. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med 354: 2552-2563.
40. Haider, D. G., Schindler, K., Prager, G. et al. 2007. Serum retinol-binding protein 4 is reduced after weight loss in morbidly obese subjects. J Clin Endocrinol Metab 92: 1168-1171.
41. Han, S. H., Chin, B. S., Lee, H. S. et al. 2009. Serum retinol-binding protein 4 correlates with obesity, insulin resistance, and dyslipidemia in HIV-infected subjects receiving highly active antiretroviral therapy. Metabolism 58: 1523-1529.
42. Henze, A., Frey, S. K., Reila, J. et al. 2008. Evidence that kidney function but not type 2 diabetes determines retinol-binding protein 4 serum levels. Diabetes 57: 3323-3326.
43. Henze, A., Raila, J., Kempf, C. et al. 2011. Vitamin A metabolism is changed in donors after living kidney transplantation: An observational study. Lipids Health Dis 10: 231.
44. Hermsdorff, H. H., Zulet, M. A., Puchau, B. et al. 2010. Central adiposity rather than total adiposity measurements are specifically involved in the inflammatory status from healthy young adults. Inflammation 34: 161-170.
45. Hu, C., Jia, W., Zang, R. et al. 2008. Effect of RBP4 gene variants on circulating RBP4 concentration and type 2 diabetes in a Chinese population. Diabetes Med 25: 11-18.
46. Ingelsson, E., Sundstrom, J., Melhus, H. et al. 2009. Circulating retinol-binding protein 4, cardiovascular risk factors and prevalent cardiovascular disease in elderly. Atherosclerosis 206: 239-244.
47. Jaconi, S., Saurat, J. H., and Siegenthaler, G. 1996. Analysis of normal and truncated holo-and apo-retinol binding protein (RBP) in human serum: Altered ratios in chronic renal failure. Eur J Encrinol 134: 576-582.
48. Janke, J., Engeli, S., Boschmann, M. et al. 2006. Retinol-binding protein 4 in human obesity. Diabetes 55: 2805-2810.
49. Jia, W., Wu, H., Bao, Y. et al. 2007. Association of serum retinol-binding protein 4 and visceral adiposity in Chinese subjects with and without type 2 diabetes. J Clin Endocrinol Metab 92: 3224-3229.
50. Kahn, B. B. and Flier, J. S. 2000. Obesity and insulin resistance. J Clin Invest 106: 473-481.
51. Kanai, M., Raz, A., and Goodman, D. S. 1968. Retinol binding protein: The transport protein for vitamin A in human plasma. J Clin Invest 47: 2025-2044.
52. Kawaguchi, R., Yu, J., Honda, J. et al. 2007. A membrane receptor for retinol binding protein mediates cellular uptake of vitamin A. Science 315: 820-825.
53. Kelly, K. R., Kashyap, S. R., O’Leary, V. B. et al. 2010. Retinol-binding protein 4 (RBP4) protein expression is increased in omental adipose tissue of severely obese patients. Obesity 18: 663-666.
54. Kershaw, E. E. and Flier, J. S. 2004. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 89: 2548-2556.
55. Kim, I. K., Lee, H. J., Kang, J. H. et al. 2011. Relationship of serum retinol-binding protein 4 with weight status and lipid profile among Korean children and adults. Eur J Clin Nutr 65: 226-233.
56. Klein, K., Bancher-Todesca, D., Leipold, H. et al. 2010. Retinol-binding protein 4 in patients with gestational diabetes mellitus. J Womens Health 19: 517-521.
57. Kloting, N., Fasshauer, M., Deitrich, A. et al. 2010. Insulin-sensitive obesity. Am J Physiol Endocrinol Metab 299: E506-E515.
58. Kovacs, P., Geyer, M., Berndt, J. et al. 2007. Effects of genetic variation in the human retinol binding protein 4 gene (RBP4) on insulin resistance and fat depot-specific mRNA expression. Diabetes 56: 3095-3100.
59. Krzyzanowska, K., Zemany, L., Krugluger, W. et al. 2008. Serum concentrations of retinol-binding protein 4 in women with and without gestational diabetes. Diabetologia 51: 1115-1122.
60. Ku, Y. H., Han, K. A., Ahn, H. et al. 2010. Resistance exercise did not alter intramuscular adipose tissue but reduced retinol-binding protein-4 concentration in individuals with type 2 diabetes mellitus. J Intl Med Res 38: 782-791.
61. Kuzmicki, M., Telejko, B., Wawrusiewicz-Kurylonek, N. et al. 2011. Retinol-binding protein 4 in adipose and placental tissue of women with gestational diabetes. Gynecol Endocrinol 27: 1065-1069.
62. Labrecque, J., Dumas, F., Lacroix, A. et al. 1995. A novel isozyme of aldehyde dehydrogenase specifically involved in the biosynthesis of 9-cis and all-trans retinoic acid. Biochem J 305: 681-684.
63. Lebovitz, H. E. and Banerji, M. A. 2001. Insulin resistance and its treatment by thiazolodinediones. Rec Prog Horm Res 56: 265-410.
64. Lee, D. C., Lee, J. W., and Im J. A. 2007. Association of serum retinol binding protein 4 and insulin resistance in apparently healthy adolescents. Metabolism 56: 327-331.
65. Lee, J. W., Im, J. A., Lee, H. R. et al. 2007. Visceral adiposity is associated with serum retinol binding protein-4 levels in healthy women. Obesity 15: 2225-2232.
66. Lee, J. W., Lee, H. R., Shim, J. Y. et al. 2008. Abdominal visceral fat reduction is associated with favourable changes of serum retinol-binding protein 4 in nondiabetic subjects. Endocrine J 55: 811-818.
67. Lenhard, J. M. 2001. PPAR gamma/RXR as a molecular target for diabetes. Receptors Channels 7: 248-258.
68. Lim, S., Choi, S. H., Jeong, I. K. et al. 2008. Insulin-sensitizing effects of exercise on adiponectin and retinol binding-4 concentrations in young and middle aged women. J Endocrinol Metab 93: 2263-2268.
69. Lim, S., Yoon, J. W., Choi, S. H. et al. 2010. Combined impact of adiponectin and retinol-binding protein 4 on metabolic syndrome in elderly people: The Korean longitudinal study on health and aging. Obesity 18: 826-832.
70. Mader, S., Chen, J. Y., Chen, Z. et al. 1993. The patterns of binding affinities of RAR, RXR and TR homo-and heterodimers to direct repeats are dictated by the binding specificities of the DNA binding domains. EMBO J 15: 5029-5041.
71. Makeover, A., Soprano, D. R., Wyatt, M. L. et al. 1989. Localization of retinol-binding protein messenger RNA in the rat kidney and in perinephric fat tissue. J Lipid Res 30: 171-180.
72. Makino, S., Fujiwara, M., Suzukawa, K. et al. 2009. Visceral obesity is associated with the metabolic syndrome and elevated plasma retinol-binding protein-4 level in obstructive sleep apnea syndrome. Horm Metab Res 41: 221-226.
73. Manolescu, D. C., Sima, A., and Bhat, P. V. 2010. All-trans retinoic acid lowers serum retinol-binding protein 4 concentrations and increases insulin sensitivity in diabetic mice. J Nutr 140: 311-316.
74. Masaki, T., Anan, F., Tsubone, T. et al. 2008. Retinol binding protein 4 concentrations are influenced by renal function in patients with type 2 diabetes. Metabolism 57: 1340-1344.
75. Mathews, K. A., Rhoten, W. B., Driscoll, H. K. et al. 2004. Vitamin A deficiency impairs fetal islet development and causes subsequent glucose intolerance in adult rats. J Nutr 134: 1958-1963.
76. Mellati, A. A., Sharifi, F., Sajadinejad, M et al. 2012. The relationship between retinol-binding protein 4 levels, insulin resistance, androgen hormones and polycystic ovary syndrome. Scand J Clin Lab Invest 72: 39-44.
77. Metzer, D., Imai T., Jiang, M. et al. 2005. Functional role of RXRs and PPAR gamma in mature adipocytes. Prostaglandins Leukot Essent Fatty Acids 73: 51-58.
78. Mills, J. P., Furr, H. C., and Tanumihardjo, S. A. 2008. Retinol to retinol-binding protein (RBP) is low in obese adults due to elevated apo-RBP. Exp Biol Med 233: 1255-1261.
79. Mody, N., Graham, T. E., Tsuji, Y et al. 2008. Decreased clearance of serum retinol-binding protein and elevated levels of transthyretin in insulin-resistant ob/ob mice. Am J Physiol Metab 294: E785-E793.
80. Mohapatra, J., Sharma, M., Acharya, A. et al. 2011. Retinol-binding protein 4: A possible role in cardiovascular complications. Br J Pharmacol 164: 1939-1948.
81. Mostafaie, N., Sebesta, C., Zehetmayer, S. et al. 2011. Circulating retinol-binding protein 4 and metabolic syndrome in the elderly. Wien Med Wochenschr 161: 505-510.
82. Motani, A., Zhulun, W., Conn, M. et al. 2009. Identification and characterization of a non-retinoid ligand for retinol-binding 4 levels in vivo. J Biol Chem 284: 7673-7680.
83. Mukherjee, R., Davies, P. J., Crombie, D. L. et al. 1997. Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonist. Nature 386: 407-410.
84. Munkhtulga, L., Nagashima, S., Nakayama, K. et al. 2010. Regulatory SNP in the RBP4 gene modified the expression in adipocytes and associated with BMI. Obesity 18: 1006-1014.
85. Napoli, J. L. 2000. Retinoic acid: Its biosynthesis and metabolism. Prog Nucleic Acid Res 63: 139-188.
86. Oberbach, A., Bluher, M., Wirth, H. et al. 2011. Combined proteomic and metabolomic profiling of serum reveals association of the complement system with obesity and identifies novel markers of body fat mass changes. J Proteome Res 10: 4769-4788.
87. Ortega-Senovilla, H., Schaefer-Graf, U., Meitzner, K. et al. 2011. Gestational diabetes mellitus causes changes in the concentrations of adipocyte fatty acid-binding protein and other adipokines in cord blood. Diabetes Care 34: 2061-2066.
88. Ost, A., Danielsson, A., Liden, M. et al. 2007. Retinol-binding protein-4 attenuates insulin-induced phosphorylation of IRS1 and ERK1/2 in primary human adipocytes. FASEB J 21: 3696-3704.
89. Ou, H. Y., Wu, H. T., Yang, Y. C. et al. 2011. Elevated retinol binding protein 4 contributes to insulin resistance in spontaneously hypertensive rats. Horm Metab Res 43: 312-318.
90. Pala, A., Monami, M., Ciani, S. et al. 2012. Adipokines as possible new predictors of cardiovascular diseases: A case control study. J Nutr Metab 2012: 253428.
91. Park, C. S., Ihm, S. H., Park, H. J. et al. 2011. Relationship between plasma adiponectin, retinol binding protein 4 and uric acid in hypertensive patients with metabolic syndrome. Korean Circ J 41: 198-202.
92. Pasutto, F., Sticht, H., Hammersen, G. et al. 2007. Mutations in STRA6 cause a broad spectrum of malformations including anophthalmia, congenital heart defects, diaphragmatic hernia, alveolar capillary dysplasia, lung hypoplasia, and mental retardation. Am J Hum Genet 80: 550-560.
93. Petersen, K. F. and Shulman, G. I. 2006. Etiology of insulin resistance. Am J Med 119: S10-S16.
94. Peterson, P. A. 1971. Characterization of a vitamin A transport protein complex occurring in human serum. J Biol Chem 246: 34-43.
95. Pocai, A., Obici, S., Schwartz, G. J. et al. 2005. A brain-liver circuit regulates glucose homeostasis. Cell Metab 1: 53-61.
96. Preitner, F., Mody, N., Graham, T. E. et al. 2009. Long-term Fenretinide treatment prevents high-fat diet-induced obesity, insulin resistance, and hepatic steatosis. Am J Physiol Endocrinol Metab 297: E1420-E1429.
97. Promintzer, M., Krebs, M., Todoric, J. et al. 2007. Insulin resistance is unrelated to circulating retinol binding protein and protein C inhibitor. J Clin Endocrinol Metab 92: 4306-4312.
98. Qatanani, M. and Lazar, M. A. 2007. Mechanisms of obesity-associated insulin resistance: Many choices on the menu. Genes Dev 21: 1443-1455.
99. Quadro, L., Blaner, W. S., Hamberger, L. et al. 2002. Muscle expression of human retinol-binding protein (RBP). Suppression of the visual defect of RBP knockout mice. J Biol Chem 277: 30191-30197.
100. Quadro, L., Blaner, W. S., Hamberger, L. et al. 2004. The role of extrahepatic retinol binding protein in the mobilization of retinoid stores. J Lipid Res 45: 1975-1982.
101. Raila, J., Henze, A., Spranger, J. et al. 2007. Microalbuminuria is a major determinant of elevated plasma retinol-binding protein 4 in type 2 diabetic patients. Kidney Intl 72: 505-511.
102. Rajala, M. W. and Scherer, P. E. 2003. The adipocyte… at the crossroads of energy homeostasis, inflammation, and atherosclerosis. Endocrinology 144: 3765-3773.
103. Reichert, B., Yasmeen, R., Jeyakumar, S. M. et al. 2011. Concerted action of aldehyde dehydrogenases influences depot-specific fat formation. Mol Endocrinol 25: 799-809.
104. Reinehr, T., Stoffel-Wagner, B., and Roth, C. L. 2008. Retinol-binding protein 4 and its relation to insulin resistance in obese children before and after weight loss. J Clin Endocrinol Metab 93: 2287-2293.
105. Rhie, Y. J., Choi, B. M., Eun, S. H. et al. 2011. Association of serum retinol binding protein 4 with adiposity and pubertal development in Korean children and adolescents. J Korean Med Sci 26: 797-802.
106. Ribel-Madsen, R., Friedrichsen, M., Vaag, A. et al. 2009. Retinol-binding protein 4 in twins. Regulatory mechanisms and impact of circulating and tissue expression levels on insulin secretion and action. Diabetes 58: 54-60.
107. Rosen, E. D. and Spiegelman, B. M. 2001. PPAR gamma: A nuclear regulator of metabolism, differentiation, and cell growth. J Biol Chem 276: 37731-37734.
108. Salgado-Somoza, A., Teijeira-Fernandez, E., Rubio, J. et al. 2012. Coronary artery disease is associated with higher epicardial retinol-binding protein 4 (RBP4) and lower glucose transporter (GLUT) 4 levels in epicardial and subcutaneous adipose tissue. Clin Endocrinol 76: 51-58.
109. Saltiel, A. R. and Kahn, C. R. 2001. Insulin signaling and the regulation of glucose and lipid metabolism. Nature 414: 799-806.
110. Samaras, K., Botelho, N. K., and Chisholm, D. J. 2010. Subcutaneous and visceral adipose tissue gene expression of serum adipokines that predict type 2 diabetes. Diabetes 18: 884-889.
111. Santoro, N., Perrone, L., Cirillo, G. et al. 2009. Variations of retinol binding protein 4 levels are not associated with changes in insulin resistance during puberty. J Endocrinol Invest 32: 411-414.
112. Sasaki, M., Otani, T., Kawakami, M. et al. 2010. Elevation of plasma retinol-binding protein 4 and reduction of plasma adiponectin in subjects with cerebral infarction. Metabolism 59: 527-532.
113. Saucedo, R., Zarate, A., Basurto, L. et al. 2011. Relationship between circulating adipokines and insulin resistance during pregnancy and postpartum in women with gestational diabetes. Arch Med Res 42: 318-323.
114. Scarpioni, L., Dall’aglio, P. P., Poisetti, P. G. et al. 1976. Retinol binding protein in serum and urine of glomerular and tubular nephropathies. Clin Chim Acta 68: 107-113.
115. Shehab-Elden, W., Shoeb, S., Khamis, S. et al. 2009. Susceptibility to insulin resistance after kidney donation: A pilot observational study. Am J Nephrol 30: 371-376.
116. Shepherd, P. R. and Khan, B. B. 1999. Glucose transporters and insulin action-implications for insulin resistance and diabetic mellitus. N Engl J Med 341: 248-257.
117. Silha, J. V., Gregoire-Nyomba, B. L., Leslie, W. D. 2007. Ethinicity, insulin resistance, and inflammatory adipokines in women at high and low risk for vascular disease. Diabetes Care 30: 286-291.
118. Sima, A., Manolescu, D-C., and Bhat, P. V. 2011. Retinoids and retinoid-metabolic gene expression in mouse adipose tissues. Biochem Cell Biol 89: 578-584.
119. Sopher, A. B., Gerken, A. T., Blaner W. S. et al. 2012. Metabolic manifestations of polycystic ovary syndrome in nonobese adolescents: Retinol-binding protein 4 and ectopic fat deposition. Fertil Steril 97: 1009-1015.
120. Soprono, D. R. and Blaner, W. S. 1994. Plasma retinol-binding protein. In: The Retinoids: Biology, Chemistry and Medicine, M. B. Sporn, A. B. Roberts, and D. S. Goodman, eds. Raven Press, New York: 257-282.
121. Stefan, N., Hennige, A. M., and Staiger, H. 2007. High circulating retinol-binding protein 4 is associated with elevated liver fat but not with total, subcutaneous, visceral, or intramyocellular fat in humans. Diabetes Care 30: 1173-1178.
122. Stuck, B. J. and Kahn, B. B. 2009. Retinol binding protein 4 (RBP4): A biomarker for subclinical atherosclerosis. Am J Hypertens 22: 948-949.
123. Su, Y. X., Hong, J., Yan, Q. et al. 2010. Increased serum retinol-binding protein-4 levels in pregnant women with and without gestational diabetes mellitus. Diabetes Metab 36: 470-475.
124. Suh, J. B., Kim, S. M., Cho, G. J. et al. 2010. Elevated serum retinol-binding protein 4 is associated with insulin resistance in older women. Metabolism 59: 118-122.
125. Tan, Y., Sun, L. Q., Kamal, M. A. et al. 2011. Suppression of retinol-binding protein 4 with RNA oligonucleotide prevents high-fat diet-induced metabolic syndrome and non-alcoholic fatty liver disease in mice. Biochim Biophys Acta 1811: 1045-1053.
126. Tomaszewski, M., Charchar, F. J., Maric, C. et al. 2007. Glomerular hyperfiltration: A new marker of metabolic risk. Kidney Int 71: 816-821.
127. Tsutsumi, C., Okuno, M., Tannous, L. et al. 1992. Retinoids and retinoid-binding protein expression in rat adipocytes. J Biol Chem 267: 1805-1810.
128. Ulgen, F., Herder, C., Kuhn, M. C. et al. 2010. Association of serum levels of retinol-binding protein 4 with male sex but not with insulin resistance in obese patients. Arch Physiol Biochem 116: 57-62.
129. van Hoek, M., Dehghan, A., Zillikens, M. C. et al. 2008. An RBP4 promoter polymorphism increases risk of type 2 diabetes. Diabetologia 51: 1423-1428.
130. Villarroya, F., Giralt, M., and Iglesias, R. 1999. Retinoids and adipose tissue: Metabolism, cell differentiation and gene expression. Int J Obes Relat Metab Disord 23: 1-6.
131. Vitkova, M., Klimcakova, E., Kovacikova, M. et al. 2007. Plasma levels and adipose tissue messenger ribonucleic acid expression of retinol-binding protein 4 are reduced during calorie restriction in obese subjects but are not related to diet-induced changes in insulin sensitivity. J Clin Endocrinol Metab 92: 2330-2335.
132. Vogel, S., Piantedosi, R., O’Bryme, S. M. et al. 2002. Retinol-binding protein-deficient mice: Biochemical basis for impaired vision. Biochemistry 41: 15360-15368.
133. von Eynatten, M., Lepper, P. M., Liu, D. et al. 2007. Retinol-binding protein 4 is associated with components of metabolic syndrome, but not with insulin resistance, in men with type 2 diabetes or coronary heart disease. Diabetologia 50: 1930-1937.
134. Weisberg, S. P. McCann, D. Desai, M. et al. 2003. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112: 1789-1808.
135. Wu, H., Wei, L., Bao, Y. et al. 2009. Fenofibrate reduces serum retinol-binding protein-4 by suppressing its expression in adipose tissue. Am J Physiol Endocrinol Metab 296: E628-E634.
136. Xu, M., Li, X. Y., Wang, J. G. et al. 2009. Retinol binding protein 4 is associated with impaired glucose regulation and microalbuminuria in a Chinese population. Diabetologia 52: 1511-1519.
137. Yagmur, E., Weiskirchen, R., Gressner, A. M. et al. 2007. Insulin resistance in liver cirrhosis is not associated with circulating retinol-binding protein 4. Diabetes Care 30: 1168-1172.
138. Yang, Q., Graham, T. E., Mody, N. et al. 2005. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 436: 356-362.
139. Yao-Borengasser, A., Varma, V., Bodles, A. M. et al. 2007. Retinol binding protein 4 expression in humans: Relationship to insulin resistance, inflammation, and response to pioglitazone. J Clin Endocrinol Metab 92: 2590-2597.
140. Yeste, D., Vendrell, J., Tomasini, R. et al. 2010. Retinol-binding protein 4 levels in obese children and adolescents with glucose intolerence. Horm Res Pediat 73: 335-340.
141. Zang, X. K., Lehman, J., Hoffmann, B. et al. 1992. Homodimer formation of retinoid X receptor induced by 9-cis retinoic acid. Nature 358: 587-591.